FIELD: medicine, pharmaceutical agents.
SUBSTANCE: disclosed is A-naphthylacetic acid and sodium, potassium and lithium salts thereof having immunomodulatory (based on leukocyte levels in patient blood suffering from viral infection), anti-inflammation (based on normalizing of erythrocyte sedimentation rate and monocytes in patient blood) and anti-tumor properties (in patient suffering from lymphomatoid granulomatosis and carcinoma of lung). Said salts are produced by treatment of A-naphthylacetic acid with solution of NaOH, or KOH, or LiOH, addition of heated distilled water in obtained solution, keeping at the same temperature to produce bright solution, followed by cooling and drying.
EFFECT: preparation with increased effectiveness, having no allergic action and other site effects.
3 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRUGS HAVING IMMUNOMODULATORY, ANTI-INFLAMMATORY AND ANTI-TUMOR PROPERTIES AND METHOD FOR PRODUCTION THEREOF | 2004 |
|
RU2295338C2 |
| MEDICINAL AGENT | 2004 |
|
RU2268037C1 |
| MEDICINAL PREPARATION AND METHOD OF ITS PREPARING | 2001 |
|
RU2193883C1 |
| DRUG | 2005 |
|
RU2320333C2 |
| PHARMACEUTICAL AGENT | 2006 |
|
RU2308270C1 |
| PHARMACEUTICAL COMPOSITION WITH IMMUNOMODULATORY, IMMUNOCORRECTING, IMMUNOSUPPRESSIVE, ANTIVIRAL, ANTI-INFLAMMATORY AND ONCOLYTIC ACTIVITIES | 2021 |
|
RU2775008C1 |
| MEDICINAL PREPARATION | 2003 |
|
RU2238730C1 |
| MEDICINAL AGENT | 2004 |
|
RU2257200C1 |
| USING 2-CHLOROETHYLPHOSPHONIC ACID AS ANTITUMOR AGENT | 2002 |
|
RU2309747C2 |
| APPLICATION OF LIQUID CRYSTALS AS MEDICAL PRODUCTS | 2008 |
|
RU2385153C1 |
